JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, W.
Right arrow Articles by Chavkin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, W.
Right arrow Articles by Chavkin, C.

Vol. 281, Issue 1, 123-128, 1997

Kappa Opioid Receptor Tolerance in the Guinea Pig Hippocampus1

Wenzhen Jin, Gregory W. Terman and Charles Chavkin

Departments of Pharmacology (W.J., C.C.) and Anesthesiology (G.W.T.), University of Washington, Seattle, Washington

We investigated whether chronic, in vivo administration of U50,488H, a kappa-1 opioid agonist, caused the development of tolerance to both the electrophysiological effects of applied kappa opioids and endogenously released dynorphins. In hippocampal slices from drug-naive guinea pigs, application of U69,593, a kappa-1 agonist, produced a concentration-dependent inhibition (EC50 = 20 nM) of the amplitude of the granule cell population response in the dentate gyrus. In slices from chronically U50,488H-treated animals, the concentration-response curve for U69,593 was shifted 3-fold to the right (EC50 = 59 nM), with a significant decrease in the maximal effect of U69,593. We also found that the effects of endogenously released dynorphins were significantly attenuated by chronic U50,488H treatment. There was no cross-tolerance between kappa and mu opioid receptor agonists as measured with the in vitro electrophysiological assay, and the noncompetitive N-methyl-D-aspartate receptor antagonist MK801 did not prevent the development of tolerance to either the electrophysiological effects or the hypothermic effects of kappa opioids. Our study demonstrates that receptor-selective tolerance to the kappa opioid actions in the guinea pig hippocampus does develop after chronic U50,488H treatment; but, unlike the mechanisms reported to underlie tolerance to kappa opioid analgesia, the inhibitory effects in the hippocampus did not depend on activation of N-methyl-D-aspartate receptors.

Copyright © by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. P. McLaughlin, L. C. Myers, P. E. Zarek, M. G. Caron, R. J. Lefkowitz, T. A. Czyzyk, J. E. Pintar, and C. Chavkin
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
J. Biol. Chem., January 16, 2004; 279(3): 1810 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. T. Williams, M. J. Christie, and O. Manzoni
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Physiol Rev, January 1, 2001; 81(1): 299 - 343.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J.-G. Li, J. L. Benovic, and L.-Y. Liu-Chen
Mechanisms of Agonist-Induced Down-Regulation of the Human kappa -Opioid Receptor: Internalization Is Required for Down-Regulation
Mol. Pharmacol., October 1, 2000; 58(4): 795 - 801.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
F. C. Dalman and K. L. O'Malley
kappa -Opioid Tolerance and Dependence in Cultures of Dopaminergic Midbrain Neurons
J. Neurosci., July 15, 1999; 19(14): 5750 - 5757.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. C. Villacres, S. T. Wong, C. Chavkin, and D. R. Storm
Type I Adenylyl Cyclase Mutant Mice Have Impaired Mossy Fiber Long-Term Potentiation
J. Neurosci., May 1, 1998; 18(9): 3186 - 3194.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Zhu, L.-Y. Luo, G.-F. Mao, B. Ashby, and L.-Y. Liu-Chen
Agonist-Induced Desensitization and Down-regulation of the Human Kappa Opioid Receptor Expressed in Chinese Hamster Ovary Cells
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 28 - 36.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.